ABSTRACT The increasing use of activated platelet rich plasma (PRP), or platelet gel, for wound healing has highlighted the disadvantages of using bovine thrombin (BT), an animal derived platelet activator, including high cost and antibody stimulation. This has motivated the exploration of direct (conductive coupling) and indirect (capacitive coupling) electrostimulation for ex vivo PRP activation to similar levels as BT in terms of growth factor release. PRP is a complex biological matrix comprising other blood cell types besides platelets. This paper assesses the impact of electrostimulation on other blood cells, specifically hematopoietic stem cells and fibroblasts. Capacitive coupling induces similar levels of cell viability and proliferation as BT 14 days following electrostimulation, while conductive coupling induces lower viability and proliferation. This indicates the potential tunability of electrostimulation to achieve equivalent efficacy as BT without the associated disadvantages and motivates future experiments to assess the implications on in vivo wound healing.
I. INTRODUCTION
The topical usage of activated platelet rich plasma (PRP), or platelet gel, for wound healing has increased dramatically over the past two decades [1] . The workflow typically includes drawing the patient's blood, separating the PRP by centrifugation (with PRP having few times the platelet concentration compared to whole blood), activating the platelets with a biochemical agent (usually bovine thrombin), and applying the resulting platelet gel topically on a wound [2] . Bovine thrombin (BT) introduces several significant disadvantages for activation, including high cost, workflow complexity, stimulation of antibody formation that may induce severe hemorrhage or thrombosis, and the requirement of special storage conditions [3] . These challenges have motivated studies into alternative platelet activation methods not requiring animal derived activators. For instance, one commercial alternative is the Plateletex-Act, which uses calcium gluoconate and batroxobin [4] , [5] , which is a thrombin-like enzyme derived from Bothrops atrox snake venom that activates and clots fibrinogen; however, the PRP generated using batroxobin induces much slower growth factor release than thrombin [4] , [6] , leading to delayed batroxobin-induced clot retraction [7] . Calcium gluconate has also been applied for platelet activation in various clinical conditions [8] - [10] . An alternative physical approach uses electric stimulation [3] , [11] - [16] . Electric pulses (EPs) with durations ranging from nanoseconds to microseconds effectively activate platelets, as indicated by the release of growth factors critical for wound healing, such as EGF (epidermal growth factor), VEGF (vascular endothelial growth factor), and PDGF (platelet derived growth factor). The growth factors released by electrical stimulation triggered the same cell proliferation levels as the growth factors released by BT [3] . The current hypothesis is that EPs permeabilize the plasma membranes of the platelets to facilitate calcium transport into the cell, while also permeabilizing intracellular structures to induce the release of intracellular calcium stores [11] , although the equal effectiveness of microsecond duration pulses suggests a more dominant membrane effect [12] , [13] . Because of the potential challenges of electrode contact for workflow issues and potential sample contamination due to electrode ion release, we have also considered the impact of capacitive coupling, where one or both of the electrodes may not make direct contact with the solution/PRP [14] . Experiments using a capacitor to represent capacitive coupling demonstrated similar levels of growth factor as those treated with bovine thrombin [14] , despite lower applied voltage and induced membrane voltage than conventional conductive coupling [17] . These results suggest that platelet activation does not require strong electric stimulation as in other applications, such as cancer treatment [18] , [19] .
PRP and whole blood are complex biological matrices containing numerous cell types, besides platelets. Ongoing research has explored the therapeutic potential of activated platelets from whole blood instead of PRP for easier, faster, less expensive workflows [20] . Using whole blood instead of PRP dramatically shortens the total workflow since it eliminates the centrifugation step to separate PRP from whole blood, which takes approximately 15-20 min [3] and requires a sterile kit. Moreover, while recent work has focused on electrical stimulation of PRP for activation [3] , [11] - [14] , future research may consider direct electrical stimulation of whole blood for platelet activation, towards rapid, inexpensive clinical workflows that would still utilize the growth factors released from platelets. Both whole blood and PRP are complex biological matrices, containing multiple cell types besides platelets, including red blood cells, white blood cells, and stem cells. This raises the question of the impact of these EPs on other cells that may be present in the PRP undergoing activation. To start addressing this question, the current study examines the impact of EPs optimized for platelet activation on mesenchymal (MSCs) and hematopoietic (HSCs) stem cells, which one may find in a complex biological matrix containing platelets. Peripheral blood contains some HSCs, while MSCs arise in various tissues, such as fat and the epidermis, but they are also identified in peripheral whole blood as circulating MSCs [21] . For convenience, we chose bone marrow as the source material for this initial study since it contains both HSCs and MSCs [22] , [23] and the stem cell concentration is 18-fold higher in bone marrow than in peripheral blood [24] . Even then, stem cells represent only approximately 0.001% of mononucleated cells in bone marrow.
Unlike our previous work [12] - [15] , this study does not assess EP induced activation of PRP, but instead focuses on EP induced effects on stem cells, specifically to demonstrate that capacitive coupling does not adversely affect stem cell growth in a cell matrix post-stimulation. Section II details the materials and methods, including biological preparations and electric pulse applications. Section III summarizes the results. We discuss the results and make concluding remarks in Section IV.
II. MATERIALS AND METHODS

A. BIOLOGICAL PREPARATIONS
To examine electrostimulation on HSC and MSC cell growth, we incubated the cells in a suitable growth environment rather than quantifying growth factor release following electrostimulation, as done previously [14] . Similar to previous platelet activation studies, 35 mL of fresh human bone marrow was obtained from three individual donors (sourced through Lonza Walkersville Inc.). The remaining blood underwent standard density gradient centrifugation Ficoll (GE Healthcare) preparation to isolate the buffy coat, which contains mononuclear cells (MNC) and platelets. We used a NUCLEOCOUNTER R NC-200 TM (Automated Cell Counter, Chemometic) to determine cell count and viability of the MNCs following separation and prior to further processing.
The isolated samples from each donor contained lymphocytes (T cells, B cells, and NK cells), monocytes, dendritic cells, HSCs, and MSCs for a total cell population of 10.7 × 10 6 , 19.1 × 10 6 and 16.8 × 10 6 cells/mL for donors 1, 2, and 3, respectively. We delivered the EPs using conductive or capacitive coupling (c.f. Section II.B) [7] . We aliquoted the samples for electrostimulation into 0.5 mL electroporation cuvettes. Equal volumes of all samples were added to the cuvettes without normalizing the cell concentration among donors. Unpulsed controls consisted of either just buffy coat (BC) or buffy coat with bovine thrombin added (BT) placed in 0.5 mL centrifuge tubes.
Following electrostimulation, any clots were removed from each cuvette and the centrifuge tubes of the controls and transferred to a 15 mL conical tube containing trypsin, where they were aspirated to break up the clot. We then centrifuged and re-suspended the cells in ammonium chloride for 10 min to cause erythrocyte lysis. After centrifuging the cells again, we re-suspended them in growth media (Gibco DMEM/F12 with 10% FBS and Pen/Strep) before performing cell counts and determining viability.
To assess mesenchymal stem cell growth following electrostimulation, cells from all treatments were plated (100 × 20 mm tissue culture plates) in 10 mL growth media and incubated at 37 • C, 5% CO 2 with periodic media changes to select for the fibroblast (adherent) cell population. The target cell count per well (7.5 × 10 6 ) could not be achieved due to low cell populations in donor samples. The cell counts varied from 1.88 × 10 6 to 7.64 × 10 6 . We accounted for this cell concentration variability in the subsequent analysis. After two weeks, the cells were stained with propidium iodide (PI) and fluorescence intensity was measured on a Typhoon Imager (GE Healthcare). Rather than using a direct colony count, this method used fluorescent intensity to compare fibroblast proliferation after EP treatment to the unstimulated controls (BC or BT). The raw fluorescent signal was natural log transformed to better fit the data. The different treatment conditions were analyzed using a repeated measures analysis of variance (ANOVA) followed by a Tukey pairwise comparison test at the 95% confidence level (Minitab 18 software).
Because we could not normalize the cell count per well in this experiment, cell count was added as a covariate in the analysis. We report adjusted p-values due to the need for multiple comparisons between methods.
We used a colony-forming assay to assess the growth of hematopoietic progenitor cells following electrostimulation. This entailed mixing the cell population from the cuvette or centrifuge tubes into MethoCult (STEMCELL Technologies) and plating the cells (5 × 10 4 cells per well) in 35 mm grid plates for 14 days. We performed a manual colony count of HSCs (burst-forming unit-erythroid (BFU-E) and granulocyte/macrophages (CFU-GM)). BFU-E are readily recognized by their pinkish or red color due to the presence of hemoglobin. The raw values from the different treatment conditions were analyzed using the ANOVA method described in the preceding paragraph. Because we normalized cell counts in this assay, it was not necessary to adjust the analysis for cell concentration as a variable.
B. ELECTRIC PULSE GENERATOR SETUP
We used a specially designed pulse generator that modifies a Marx topology by controlling switch sequences and voltages into each capacitor stage to permit applying EPs to low and high conductivity solutions with pulse durations from nanoseconds to microseconds using a single device [15] .
We placed the samples in 2 mm commercial electroporation cuvettes that we then placed within a sample holder constructed within the pulse generator. We used a Tektronix DPO4104 oscilloscope with a Tektronix P6015A high-voltage probe (Tektronics Inc., Beaverton, OR) and a Pearson probe, model 110 (Pearson Electronics, Palo Alto, CA) to measure the applied voltage pulse and resulting electric current, respectively. We applied a single pulse for conductive coupling and eighty pairs of bipolar pulses for capacitive coupling with a pair delivered every second. Fig. 1a shows a representative monopolar pulse with amplitude ∼8.5 kV/cm and duration 5 µs delivered using conductive coupling. Note that this differs from our earlier conductive coupling studies, where we used 4 kV (20 kV/cm), 650 ns pulses [14] . In these earlier studies, we assumed that nanosecond EPs were necessary to activate platelets [11] ; however, we subsequently observed that microsecond EPs could also effectively activate platelets [13] . This led to us focus on longer duration, lower intensity EPs, which are advantageous for commercial applications since this allows the use of simpler, more reliable, and less expensive electronics than nanosecond EPs and the lower field strengths reduce the risk of arcing in the cuvette with the PRP.
We achieved capacitive coupling by placing a 1.5 nF capacitor between the pulse generator and the cuvette and applying a 500 ns, 4 kV square pulse to obtain the bipolar waveform shown in Fig. 1b . We do not expect or observe any heating for the single monopolar pulse or the low intensity, bipolar pulse train. Basal cell populations on the raw bone marrow aspirate (BMA) for three donors (D1, D2, and D3) prior to any blood processing with definitions and units in Table I . Fig. 2 shows the cell population analysis (Sysmex XE-2100 TM Automated Hematology System) of the blood samples from the three donors, with Table I defining the variables and their units. Fig. 1.   FIGURE 3 . Viability of all nucleated cells isolated from the three donors (denoted D1, D2, and D3) and exposed to electrostimulation by conductive (Cond) or capacitive (Cap) coupling and control samples of buffy coat (BC) and bovine thrombin (BT), which did not receive electrostimulation. Fig. 3 shows the viability of all isolated nucleated cells, with the electrostimulated cells measured immediately after treatment. For a given donor, the cells exposed to the EP via capacitive coupling tend to have a higher viability than those treated with conductive coupling and they tend to be equivalent to non-electrostimulated buffy coat (BC) and BT samples. Except for Donor 1 for conductive coupling, all viabilities exceeded 85%. with these EP conditions hinders long-term fibroblast growth while any impact of capacitive coupling on fibroblast growth is statistically insignificant compared to control. Fig. 4b compares hematopoietic progenitor stem cell (HSC) growth fourteen days after electrostimulation using conductive and capacitive coupling to BC and BT with no electrostimulation. The HSC count for capacitive coupling was slightly higher than the BC or BT cohorts, although the differences were not statistically significant (adjusted p-values of 0.605 and 0.366, respectively). Alternatively, conductive coupling induced a dramatic and significant decrease in HSC compared to capacitive coupling (adjusted p-value < 0.0005). As for fibroblasts, this indicates that electrostimulation by conductive coupling with the EP parameters chosen here hinders HSC growth while capacitive coupling has no statistically significant effect on HSC growth fourteen days after electrostimulation.
III. RESULTS
A. INITIAL BIOLOGICAL CELL DISTRIBUTION
B. POST-ELECTRIC PULSE RESULTS
To place these relative growth values into perspective, we show a representative image of the CFU-F growth assay using the Typhoon imaging system in Fig. 5 . Taken together with the results in Figs. 3 and 4 , this shows that treating the cells with capacitive coupling does not suppress the growth of mesenchymal stem cells by fluorescence intensity compared to the control treatments of buffy coat (BC) and bovine thrombin (BT). Conversely, treating the sample using conductive coupling greatly hinders stem cell growth. 
IV. DISCUSSION
Previous studies on electrostimulation for platelet activation have focused on growth factor release and quantifying various platelet biomarkers [3] ; however, whole blood is a complex biological matrix with many other cell types that may influence treatment efficacy when using activated PRP. Thus, we report here the first detailed results on the impact of electrostimulation protocols for platelet activation on fibroblast and hematopoietic progenitor cells using biomaterial from three different donors. Moreover, these results further elucidate the difference that arises between EP delivery using conductive and capacitive coupling, which have been previously shown to induce similar growth factor release and MCF10 (an epithelial cell line) cell proliferation, but different levels of surface P-selectin and Annexin V-positive platelets [14] .
This study shows that capacitive coupling results in higher viability and cell proliferation than conductive coupling fourteen days after treatment. Figures 4a and 4b show that capacitive coupling induces similar proliferation rates to BT, the current state of the art clinical platelet activator, while the conductive coupling conditions used here significantly reduces proliferation rates compared to BT. These results for electrostimulation of fibroblasts and hematopoietic stem cells, combined with previous findings that capacitive coupling impacts various platelet biomarkers, such as growth factor release and cell proliferation, at similar levels as bovine thrombin [14] , demonstrate that capacitive coupling may induce similar ex vivo effects on PRP activation as BT. Moreover, viability is generally higher for capacitive coupling than conductive coupling [14] , thus enabling capacitive coupling to activate platelets with fewer potential side effects. Future work may consider the potential for using capacitive coupling to affect specifically the growth of fibroblasts and hematopoietic progenitor cells for further control of wound healing.
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